159 related articles for article (PubMed ID: 15517868)
1. PAkt, cyclin D1 and p27/Kip.1 in glioblastomas with and without EGFR amplification and PTEN mutation.
Fiano V; Ghimenti C; Imarisio S; Silengo L; Schiffer D
Anticancer Res; 2004; 24(5A):2643-7. PubMed ID: 15517868
[TBL] [Abstract][Full Text] [Related]
2. Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas.
Kurose K; Zhou XP; Araki T; Cannistra SA; Maher ER; Eng C
Am J Pathol; 2001 Jun; 158(6):2097-106. PubMed ID: 11395387
[TBL] [Abstract][Full Text] [Related]
3. Mutant epidermal growth factor receptor signaling down-regulates p27 through activation of the phosphatidylinositol 3-kinase/Akt pathway in glioblastomas.
Narita Y; Nagane M; Mishima K; Huang HJ; Furnari FB; Cavenee WK
Cancer Res; 2002 Nov; 62(22):6764-9. PubMed ID: 12438278
[TBL] [Abstract][Full Text] [Related]
4. PTEN induces G(1) cell cycle arrest and decreases cyclin D3 levels in endometrial carcinoma cells.
Zhu X; Kwon CH; Schlosshauer PW; Ellenson LH; Baker SJ
Cancer Res; 2001 Jun; 61(11):4569-75. PubMed ID: 11389092
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D arrests thyroid carcinoma cell growth and induces p27 dephosphorylation and accumulation through PTEN/akt-dependent and -independent pathways.
Liu W; Asa SL; Fantus IG; Walfish PG; Ezzat S
Am J Pathol; 2002 Feb; 160(2):511-9. PubMed ID: 11839571
[TBL] [Abstract][Full Text] [Related]
6. Role of the phosphatidylinositol 3-kinase/Akt and mTOR/P70S6-kinase pathways in the proliferation and apoptosis in multiple myeloma.
Pene F; Claessens YE; Muller O; ViguiƩ F; Mayeux P; Dreyfus F; Lacombe C; Bouscary D
Oncogene; 2002 Sep; 21(43):6587-97. PubMed ID: 12242656
[TBL] [Abstract][Full Text] [Related]
7. Enhanced protein kinase B/Akt signalling in pituitary tumours.
Musat M; Korbonits M; Kola B; Borboli N; Hanson MR; Nanzer AM; Grigson J; Jordan S; Morris DG; Gueorguiev M; Coculescu M; Basu S; Grossman AB
Endocr Relat Cancer; 2005 Jun; 12(2):423-33. PubMed ID: 15947113
[TBL] [Abstract][Full Text] [Related]
8. Enhanced sensitivity of multiple myeloma cells containing PTEN mutations to CCI-779.
Shi Y; Gera J; Hu L; Hsu JH; Bookstein R; Li W; Lichtenstein A
Cancer Res; 2002 Sep; 62(17):5027-34. PubMed ID: 12208757
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor receptor, protein kinase B/Akt, and glioma response to erlotinib.
Haas-Kogan DA; Prados MD; Tihan T; Eberhard DA; Jelluma N; Arvold ND; Baumber R; Lamborn KR; Kapadia A; Malec M; Berger MS; Stokoe D
J Natl Cancer Inst; 2005 Jun; 97(12):880-7. PubMed ID: 15956649
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of ILK in PTEN-mutant human glioblastomas inhibits PKB/Akt activation, induces apoptosis, and delays tumor growth.
Edwards LA; Thiessen B; Dragowska WH; Daynard T; Bally MB; Dedhar S
Oncogene; 2005 May; 24(22):3596-605. PubMed ID: 15782140
[TBL] [Abstract][Full Text] [Related]
11. Genetic alterations and aberrant expression of genes related to the phosphatidyl-inositol-3'-kinase/protein kinase B (Akt) signal transduction pathway in glioblastomas.
Knobbe CB; Reifenberger G
Brain Pathol; 2003 Oct; 13(4):507-18. PubMed ID: 14655756
[TBL] [Abstract][Full Text] [Related]
12. Complex regulation of the cyclin-dependent kinase inhibitor p27kip1 in thyroid cancer cells by the PI3K/AKT pathway: regulation of p27kip1 expression and localization.
Motti ML; Califano D; Troncone G; De Marco C; Migliaccio I; Palmieri E; Pezzullo L; Palombini L; Fusco A; Viglietto G
Am J Pathol; 2005 Mar; 166(3):737-49. PubMed ID: 15743786
[TBL] [Abstract][Full Text] [Related]
13. PTEN coordinates G(1) arrest by down-regulating cyclin D1 via its protein phosphatase activity and up-regulating p27 via its lipid phosphatase activity in a breast cancer model.
Weng LP; Brown JL; Eng C
Hum Mol Genet; 2001 Mar; 10(6):599-604. PubMed ID: 11230179
[TBL] [Abstract][Full Text] [Related]
14. [PTEN expression in endometrial cancer and the prognosis].
Kanamori Y; Uegaki K; Kigawa J; Terakawa N
Nihon Rinsho; 2004 Oct; 62 Suppl 10():406-9. PubMed ID: 15535277
[No Abstract] [Full Text] [Related]
15. PTEN induces cell cycle arrest by decreasing the level and nuclear localization of cyclin D1.
Radu A; Neubauer V; Akagi T; Hanafusa H; Georgescu MM
Mol Cell Biol; 2003 Sep; 23(17):6139-49. PubMed ID: 12917336
[TBL] [Abstract][Full Text] [Related]
16. Herceptin-induced inhibition of phosphatidylinositol-3 kinase and Akt Is required for antibody-mediated effects on p27, cyclin D1, and antitumor action.
Yakes FM; Chinratanalab W; Ritter CA; King W; Seelig S; Arteaga CL
Cancer Res; 2002 Jul; 62(14):4132-41. PubMed ID: 12124352
[TBL] [Abstract][Full Text] [Related]
17. ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways.
Lenferink AE; Busse D; Flanagan WM; Yakes FM; Arteaga CL
Cancer Res; 2001 Sep; 61(17):6583-91. PubMed ID: 11522658
[TBL] [Abstract][Full Text] [Related]
18. PTEN expression is reduced in a subset of sporadic thyroid carcinomas: evidence that PTEN-growth suppressing activity in thyroid cancer cells mediated by p27kip1.
Bruni P; Boccia A; Baldassarre G; Trapasso F; Santoro M; Chiappetta G; Fusco A; Viglietto G
Oncogene; 2000 Jun; 19(28):3146-55. PubMed ID: 10918569
[TBL] [Abstract][Full Text] [Related]
19. Cyclin D1 and c-myc internal ribosome entry site (IRES)-dependent translation is regulated by AKT activity and enhanced by rapamycin through a p38 MAPK- and ERK-dependent pathway.
Shi Y; Sharma A; Wu H; Lichtenstein A; Gera J
J Biol Chem; 2005 Mar; 280(12):10964-73. PubMed ID: 15634685
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC.
Haas-Kogan D; Shalev N; Wong M; Mills G; Yount G; Stokoe D
Curr Biol; 1998 Oct; 8(21):1195-8. PubMed ID: 9799739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]